Market Pulse
GSK posts promising results from gonorrhoea treatment trial
GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.
Wednesday newspaper round-up: IMF, champagne, Boeing, Plus500, Trump Media
Rising energy prices and disruption to international shipping risk “stalling” declines in inflation in leading economies, the International Monetary Fund has warned, telling central banks that the “last mile” of their battle against price rises may be the hardest. In its latest assessment of global financial stability, the IMF said markets were vulnerable to another round of volatility if investors continued to push back their expectations for interest rate cuts this year, leading to falls in bond and stock prices.